MJP Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
3,254
-108
-3% -$9.45K 0.03% 167
2026
Q1
$287K Buy
+3,362
New +$300K 0.03% 166
2025
Q3
– Sell
-2,212
Closed -$201K – 257
2025
Q2
$201K Buy
+2,212
New +$202K 0.03% 228
2024
Q4
– Sell
-1,966
Closed -$204K – 236
2024
Q3
$204K Sell
1,966
-147
-7% -$15K 0.04% 204
2024
Q2
$205K Buy
+2,113
New +$195K 0.04% 223
2021
Q1
– Sell
-2,566
Closed -$219K – 130
2020
Q4
$219K Buy
+2,566
New +$212K 0.09% 107

Other funds holding CL

MJP Associates's CL Position: Q2 2026 in Review

MJP Associates reduced its Colgate-Palmolive (CL) stake by 3.2% in Q2 2026, selling an estimated $9.45K and leaving 3,254 shares worth $298K. The position accounts for 0.03% of the portfolio, ranked #167.

MJP Associates first reported a position in CL in Q4 2020 and has held it in 6 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • MJP Associates held 3,254 shares of Colgate-Palmolive worth $298K as of Q2 2026.
  • MJP Associates sold 108 Colgate-Palmolive shares in Q2 2026, an estimated $9.45K.
  • Colgate-Palmolive made up 0.03% of MJP Associates's portfolio in Q2 2026, its #167 holding.
  • MJP Associates first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 6 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.